Prescription Drug Diversion and Pain : History, Policy, and Treatment

個数:
電子版価格
¥9,759
  • 電書あり

Prescription Drug Diversion and Pain : History, Policy, and Treatment

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 272 p.
  • 言語 ENG
  • 商品コード 9780199981830
  • DDC分類 615.7822

Full Description

Prescription Drug Diversion and Pain provides an interdisciplinary overview of medications used to treat chronic pain, specifically the benefits and risks that are posed by long-term opioids use. These essential pain-relieving medications must be carefully managed to prevent serious side effects that may include physical dependence, addiction, and even death, which has led in recent years to increased attention on the development of alternative treatments for chronic pain. This book not only offers a single, comprehensive source for understanding the specialized field of the opioid crisis, but also addresses provocative topics including how pain drugs came to be regulated by the U.S. Government and the rarely-discussed aggressive marketing behind the spread of these drugs. Chapters are written by expert contributors from diverse backgrounds in medicine, psychiatry, pharmacy, nursing, health law, and ethics. Prescription Drug Diversion and Pain is a must-read for healthcare professionals, caregivers, policy makers, regulatory officials, law enforcement, and those in the pharmaceutical industry seeking to address the current and future opioid crisis.

Contents

Chapter 1: Opioid Medications: Old Wine in New Bottles
Timothy Atkinson, John J. Coleman, and Jeffrey Fudin
Chapter 2: Legal Regulation of Prescription Opioids and Prescribers
Kelly K. Dineen and Adam J. Ruggles
Chapter 3: Monitoring Prescriptions, Third-Party Healthcare Payers, Prescription Benefit Managers, and Private Sector Policy Options
John J. Coleman
Chapter 4: Whatever Happened to the Decade of Pain Control and Research?
John J. Coleman
Chapter 5: Evaluation and Treatment of the Chronic Pain Patient: Practice and Complexity
John F. Peppin, Pravardhan Birthi, Bill H. McCarberg, and Yvonne D'Arcy
Chapter 6: An Overview of the Abuse Potential of Non-Opioids: Sedatives, Hypnotics, and Stimulants
Christopher M. Herndon and Kelly N. Gable
Chapter 7: Psychiatry and Chronic Pain: An Associative Connection
Hani Raoul Khouzam
Chapter 8: Managing Pain in Patients with a History of a Substance Use Disorder: Challenges and Opportunities
Martin D. Cheatle
Chapter 9: Special Populations
Kelly K. Dineen
Chapter 10: The Demise of Interdisciplinary Chronic Pain Management and Its Relationship to the Scourge of Prescription Opioid Diversion and Abuse
Michael E. Schatman
Chapter 11: Pain Management Assessment Beyond the Physician Encounter: Urine Drug Monitoring and Patient Agreements
Anand C. Thakur
Epilogue
John F. Peppin, John J. Coleman, and Kelly K. Dineen